Medical hypothesis discovery and innovation in ophthalmology

Carrwik C, Stenevi U. Lattice corneal dystrophy, gelsolin type (Meretoja's syndrome). Acta Ophthalmol. 2009; 87(8): 813-819. PMID: 19832730

Weiss JS, Møller HU, Lisch W, Kinoshita S, Aldave AJ, Belin MW, Kivelä T, Busin M, Munier FL, Seitz B, Sutphin J, Bredrup C, Mannis MJ, Rapuano CJ, Van Rij G, Kim EK, Klintworth GK. The IC3D classification of the corneal dystrophies. Cornea. 2008; 27 Suppl 2: S1-83. PMID: 19337156

Meretoja J. Familial Systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes, and various internal symptoms: a previously unrecognised heritable syndrome. Ann Clin Res 1969; 1(4): 314-324.

Kiuru S. Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients. Acta Neurol Scand 1992; 86(4): 346-353. PMID: 1333716

Huerva V, Velasco A, Sánchez MC, Mateo AJ, Matías-Guiu X. Lattice corneal dystrophy type II: clinical, pathologic, and molecular study in a Spanish family. Eur J Ophthalmol 2007; 17 (3): 424-429. PMID: 17534828

Rosenberg ME1, Tervo TM, Gallar J, Acosta MC, Müller LJ, Moilanen JA, Tarkkanen AH, Vesaluoma MH. Corneal morphology and sensitivity in lattice dystrophy type II (familial amyloidosis, Finnish type). Invest Ophthalmol Vis Sci 2001; 42(3): 634–64.. PMID: 11222521